Top Banner
MIDDLE EAST RESPIRATORY SYNDROME - CORONAVIRUS DR.T.V.RAO MD
40

Middle East respiratory syndrome - coronavirus

Aug 22, 2014

Download

Health & Medicine

Middle East respiratory syndrome - corona virus
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Middle East respiratory syndrome - coronavirus

MIDDLE EAST RESPIRATORY SYNDROME

- CORONAVIRUSDR.T.V.RAO MD

Page 2: Middle East respiratory syndrome - coronavirus

WHAT IS MIDDLE EAST RESPIRATORY SYNDROME (MERS)

• MIDDLE EAST RESPIRATORY SYNDROME (MERS) IS VIRAL RESPIRATORY ILLNESS FIRST REPORTED IN SAUDI ARABIA IN 2012. IT IS CAUSED BY A CORONAVIRUS CALLED MERS-COV. MOST PEOPLE WHO HAVE BEEN CONFIRMED TO HAVE MERS-COV INFECTION DEVELOPED SEVERE ACUTE RESPIRATORY ILLNESS. THEY HAD FEVER, COUGH, AND SHORTNESS OF BREATH. ABOUT 30% OF PEOPLE CONFIRMED TO HAVE MERS-COV INFECTION HAVE DIED.

Page 3: Middle East respiratory syndrome - coronavirus

MIDDLE EAST RESPIRATORY SYNDROME (MERS) BELONGS TO

CORONAVIRUS INFECTIONS • CORONAVIRUSES ARE A LARGE

FAMILY OF VIRUSES THAT CAUSE A RANGE OF ILLNESSES IN HUMANS, FROM THE COMMON COLD TO THE SEVERE ACUTE RESPIRATORY SYNDROME (SARS). VIRUSES IN THIS FAMILY ALSO CAUSE A NUMBER OF ANIMAL DISEASES

Page 4: Middle East respiratory syndrome - coronavirus

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-

COV)• THIS STRAIN OF CORONAVIRUS THAT CAUSES MERS WAS FIRST IDENTIFIED IN 2012 IN SAUDI ARABIA. OUR UNDERSTANDING OF THE VIRUS AND THE DISEASE IT CAUSES IS CONTINUING TO EVOLVE.

Page 5: Middle East respiratory syndrome - coronavirus

STRUCTURE OF MERS VIRUS

Page 6: Middle East respiratory syndrome - coronavirus

THE INFECTION IS LINKED TO • ALL THE CASES HAVE BEEN

LINKED TO COUNTRIES IN THE ARABIAN PENINSULA. THIS VIRUS HAS SPREAD FROM ILL PEOPLE TO OTHERS THROUGH CLOSE CONTACT, SUCH AS CARING FOR OR LIVING WITH AN INFECTED PERSON. HOWEVER, THERE IS NO EVIDENCE OF SUSTAINED SPREADING IN COMMUNITY SETTINGS.

Page 7: Middle East respiratory syndrome - coronavirus

WHY PALM TRESS IN THE MERS-COV ACQUISITION MODEL...? A HYPOTHESIS?

Page 8: Middle East respiratory syndrome - coronavirus

THE MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS

• THE MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV),[1] ALSO TERMED EMC/2012 (HCOV-EMC/2012), IS POSITIVE-SENSE, SINGLE-STRANDED RNA NOVEL SPECIES OF THE GENUS BETA CORONAVIRUS.

Page 9: Middle East respiratory syndrome - coronavirus
Page 10: Middle East respiratory syndrome - coronavirus

MERS-COV REPORTED AT SEVERAL PLACES

• AS OF 14 MAY 2014, MERS-COV CASES HAVE BEEN REPORTED IN SEVERAL COUNTRIES, INCLUDING SAUDI ARABIA, MALAYSIA, JORDAN, QATAR, EGYPT, THE UNITED ARAB EMIRATES, TUNISIA, KUWAIT, OMAN, THE PHILIPPINES, INDONESIA (NONE WAS CONFIRMED), THE UNITED KINGDOM, AND THE UNITED STATES.

Page 11: Middle East respiratory syndrome - coronavirus

VIRUS AND CLADES • THE VIRUS MERS-COV IS A NEW

MEMBER OF THE BETA GROUP OF CORONAVIRUS, BETA CORONAVIRUS, LINEAGE C. MERS-COV GENOMES ARE PHYLOGENETIC ALLY CLASSIFIED INTO TWO CLADES, CLADE A AND B. THE EARLIEST CASES OF MERS WERE OF CLADE A CLUSTERS (EMC/2012 AND JORDAN-N3/2012), AND NEW CASES ARE GENETICALLY DISTINCT (CLADE B).

Page 12: Middle East respiratory syndrome - coronavirus

FIRST CASE OF MERS-COV

• THE FIRST CONFIRMED CASE WAS REPORTED IN SAUDI ARABIA 2012. EGYPTIAN VIROLOGIST DR. ALI MOHAMED ZAKI ISOLATED AND IDENTIFIED A PREVIOUSLY UNKNOWN CORONAVIRUS FROM THE MAN'S LUNGS. DR. ZAKI THEN POSTED HIS FINDINGS ON 24 SEPTEMBER 2012 ON PROMED-MAIL. THE ISOLATED CELLS SHOWED CYTOPATHIC EFFECTS (CPE), IN THE FORM OF ROUNDING AND SYNCYTIA FORMATION.

Page 13: Middle East respiratory syndrome - coronavirus

SECOND CASE OF MERS-COV

• A SECOND CASE WAS FOUND IN SEPTEMBER 2012. A 49-YEAR-OLD MALE LIVING IN QATAR PRESENTED SIMILAR FLU SYMPTOMS, AND A SEQUENCE OF THE VIRUS WAS NEARLY IDENTICAL TO THAT OF THE FIRST CASE.[4] IN NOVEMBER 2012, SIMILAR CASES APPEARED IN QATAR AND SAUDI ARABIA. ADDITIONAL CASES WERE NOTED, WITH DEATHS ASSOCIATED, AND RAPID RESEARCH AND MONITORING OF THIS NOVEL CORONAVIRUS BEGAN.

Page 14: Middle East respiratory syndrome - coronavirus

TROPISM IN MERS • IN HUMANS, THE VIRUS HAS A STRONG TROPISM FOR

NONCILIATED BRONCHIAL EPITHELIAL CELLS, AND IT HAS BEEN SHOWN TO EFFECTIVELY EVADE THE INNATE IMMUNE RESPONSES AND ANTAGONIZE INTERFERON (IFN) PRODUCTION IN THESE CELLS. THIS TROPISM IS UNIQUE IN THAT MOST RESPIRATORY VIRUSES TARGET CILIATED CELLS• DUE TO THE CLINICAL SIMILARITY BETWEEN MERS-COV AND

SARS-COV, IT WAS PROPOSED THAT THEY MAY USE THE SAME CELLULAR RECEPTOR; THE EXOPEPTIDASE, ANGIOTENSIN CONVERTING ENZYME 2 (ACE2).[14] HOWEVER, IT WAS LATER DISCOVERED THAT NEUTRALIZATION OF ACE2 BY RECOMBINANT ANTIBODIES DOES NOT PREVENT MERS-COV INFECTION.

Page 15: Middle East respiratory syndrome - coronavirus

INCUBATION PERIOD • THE MEDIAN INCUBATION PERIOD

FOR SECONDARY CASES ASSOCIATED WITH LIMITED HUMAN-TO-HUMAN TRANSMISSION IS APPROXIMATELY 5 DAYS (RANGE 2-13 DAYS). IN MERS-COV PATIENTS, THE MEDIAN TIME FROM ILLNESS ONSET TO HOSPITALIZATION IS APPROXIMATELY 4 DAYS.

Page 16: Middle East respiratory syndrome - coronavirus
Page 17: Middle East respiratory syndrome - coronavirus

COMMON CLINICAL PRESENTATIONS

• COMMON SIGNS AND SYMPTOMS INCLUDE FEVER, CHILLS/RIGORS, HEADACHE, NON-PRODUCTIVE COUGH, DYSPNEA, AND MYALGIA. OTHER SYMPTOMS CAN INCLUDE SORE THROAT, CORYZA, NAUSEA AND VOMITING, DIZZINESS, SPUTUM PRODUCTION, DIARRHEA, VOMITING, AND ABDOMINAL PAIN. ATYPICAL PRESENTATIONS INCLUDING MILD RESPIRATORY ILLNESS WITHOUT FEVER AND DIARRHEAL ILLNESS PRECEDING DEVELOPMENT OF PNEUMONIA HAVE BEEN REPORTED. PATIENTS WHO PROGRESS TO REQUIRING ADMISSION TO AN INTENSIVE CARE UNIT (ICU) OFTEN HAVE A HISTORY OF A FEBRILE UPPER RESPIRATORY TRACT ILLNESS WITH RAPID PROGRESSION TO PNEUMONIA WITHIN A WEEK OF ILLNESS ONSET.

Page 18: Middle East respiratory syndrome - coronavirus

PATIENTS PRESENT WITH WATCH FOR THESE SYMPTOMS:

• FEVER (100° FAHRENHEIT OR HIGHER). TAKE YOUR TEMPERATURE TWICE A DAY.

• COUGHING• SHORTNESS OF BREATH• OTHER EARLY SYMPTOMS TO WATCH

FOR ARE CHILLS, BODY ACHES, SORE THROAT, HEADACHE, DIARRHOEA, NAUSEA/VOMITING, AND RUNNY NOSE.

Page 19: Middle East respiratory syndrome - coronavirus

PROBABLE CASE• A PROBABLE CASE IS A PUI WITH ABSENT OR INCONCLUSIVE4 LABORATORY RESULTS FOR MERS-COV INFECTION WHO IS A CLOSE CONTACT2 OF A LABORATORY-CONFIRMED MERS-COV CASE.

Page 20: Middle East respiratory syndrome - coronavirus

PATIENT UNDER INVESTIGATION (PUI)

• A PATIENT UNDER INVESTIGATION (PUI) IS A PERSON WITH THE FOLLOWING CHARACTERISTICS: FEVER (≥38°C, 100.4°F) AND PNEUMONIA OR ACUTE RESPIRATORY DISTRESS SYNDROME (BASED ON CLINICAL OR RADIOLOGICAL EVIDENCE)

Page 21: Middle East respiratory syndrome - coronavirus

PATIENT UNDER INVESTIGATION (PUI)

• A HISTORY OF TRAVEL FROM COUNTRIES IN OR NEAR THE ARABIAN PENINSULA1 WITHIN 14 DAYS BEFORE SYMPTOM ONSET, OR

• CLOSE CONTACT2 WITH A SYMPTOMATIC TRAVELLER WHO DEVELOPED FEVER AND ACUTE RESPIRATORY ILLNESS (NOT NECESSARILY PNEUMONIA) WITHIN 14 DAYS AFTER TRAVELING FROM COUNTRIES IN OR NEAR THE ARABIAN PENINSULA

Page 22: Middle East respiratory syndrome - coronavirus

PATIENT UNDER INVESTIGATION (PUI)

• A MEMBER OF A CLUSTER OF PATIENTS WITH SEVERE ACUTE RESPIRATORY ILLNESS (E.G. FEVER AND PNEUMONIA REQUIRING HOSPITALIZATION) OF UNKNOWN AETIOLOGY IN WHICH MERS-COV IS BEING EVALUATED, IN CONSULTATION WITH STATE AND LOCAL HEALTH DEPARTMENTS.

Page 23: Middle East respiratory syndrome - coronavirus

RADIOLOGICAL FINDINGS • RADIOGRAPHIC FINDINGS

MAY INCLUDE UNILATERAL OR BILATERAL PATCHY DENSITIES OR OPACITIES, INTERSTITIAL INFILTRATES, CONSOLIDATION, AND PLEURAL EFFUSIONS. RAPID PROGRESSION TO ACUTE RESPIRATORY FAILURE, ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS),

Page 24: Middle East respiratory syndrome - coronavirus

CO-INFECTIONS IN MERS • CO-INFECTION WITH OTHER

RESPIRATORY VIRUSES AND A FEW CASES OF CO-INFECTION WITH COMMUNITY-ACQUIRED BACTERIA AT ADMISSION HAS BEEN REPORTED; NOSOCOMIAL BACTERIAL AND FUNGAL INFECTIONS HAVE BEEN REPORTED IN MECHANICALLY-VENTILATED PATIENTS.

Page 25: Middle East respiratory syndrome - coronavirus

MERS-COV AND PREGNANCY• THERE HAVE BEEN LESS OF A HANDFUL

CASES OF CONFIRMED MERS-COV IN PREGNANCY. SO IT IS VERY DIFFICULT TO DRAW CONCLUSIONS ON THE EFFECT OF MERS TO PREGNANCY. HOWEVER TRADITIONALLY PREGNANT MOTHER ARE CONSIDERED TO BE IN THE HIGH RISK GROUP FOR MERS COMPLICATIONS DUE TO THE CHANGES IN THEIR IMMUNE RESPONSE AND THE FETAL EFFECTS OF A SEVERE RESPIRATORY SYNDROME.

Page 26: Middle East respiratory syndrome - coronavirus

ROLE OF LABORATORIES • MOST STATE LABORATORIES

ARE APPROVED TO TEST FOR MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV) USING CDC'S RRT-PCR ASSAY. HOWEVER, THEY SHOULD COORDINATE WITH CDC FOR SPECIMEN TESTING SINCE WIDELY AVAILABLE DIAGNOSTIC TESTS ARE NOT SUITABLE.

Page 27: Middle East respiratory syndrome - coronavirus

WHAT SPECIMEN TO COLLECT • AS

•BRONCHO ALVEOLAR LAVAGE SPUTUM AND TRACHEAL ASPIRATES CONTAIN THE HIGHEST VIRAL LOADS AND THESE SHOULD BE COLLECTED WHEN POSSIBLE

Page 28: Middle East respiratory syndrome - coronavirus

RT-PCR THE GOLD STANDARD •USE OF CDC'S 2012 REAL-TIME REVERSE TRANSCRIPTION–PCR ASSAY TO TEST FOR MERS-COV IN CLINICAL RESPIRATORY, BLOOD, AND STOOL SPECIMENS.

Page 29: Middle East respiratory syndrome - coronavirus

WHEN TO CONSIDER AS MERS-COV INFECTION

• CLUSTERS4 OF PATIENTS WITH SEVERE ACUTE RESPIRATORY ILLNESS (E.G., FEVER AND PNEUMONIA REQUIRING HOSPITALIZATION) WITHOUT RECOGNIZED LINKS TO A CASE OF MERS-COV INFECTION OR TO TRAVELLERS FROM COUNTRIES IN OR NEAR THE ARABIAN PENINSULA SHOULD BE EVALUATED FOR COMMON RESPIRATORY PATHOGENS.3 IF THE ILLNESSES REMAIN UNEXPLAINED, PROVIDERS SHOULD CONSIDER TESTING FOR MERS-COV, IN CONSULTATION WITH STATE AND LOCAL HEALTH DEPARTMENTS.

Page 30: Middle East respiratory syndrome - coronavirus

INFECTION CONTROL MEASURES

• HEALTHCARE PERSONNEL SHOULD ADHERE TO RECOMMENDED INFECTION CONTROL MEASURES, INCLUDING STANDARD, CONTACT, AND AIRBORNE PRECAUTIONS, WHILE MANAGING SYMPTOMATIC CLOSE CONTACTS, PATIENTS UNDER INVESTIGATION, AND PATIENTS WHO HAVE PROBABLE OR CONFIRMED MERS-COV INFECTIONS. RECOMMENDED INFECTION CONTROL PRECAUTIONS SHOULD ALSO BE UTILIZED WHEN COLLECTING SPECIMENS.

Page 31: Middle East respiratory syndrome - coronavirus

PREVENTIVE MEASURES IN THE HOSPITAL

• FOCUS ON THE HOSPITAL SETTING, THE RECOMMENDATIONS FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), SOURCE CONTROL (I.E., PLACING A FACEMASK ON POTENTIALLY INFECTED PATIENTS WHEN OUTSIDE OF AN AIRBORNE INFECTION ISOLATION ROOM), AND ENVIRONMENTAL INFECTION CONTROL MEASURES ARE APPLICABLE TO ANY HEALTHCARE SETTING.

Page 32: Middle East respiratory syndrome - coronavirus

UPDATED RECOMMENDATION

• SUSPECTED HIGH RATE OF MORBIDITY AND MORTALITY AMONG INFECTED PATIENTS• EVIDENCE OF LIMITED HUMAN-TO-

HUMAN TRANSMISSION• POORLY CHARACTERIZED CLINICAL

SIGNS AND SYMPTOMS• UNKNOWN MODES OF

TRANSMISSION OF MERS-COV• LACK OF A VACCINE AND

CHEMOPROPHYLAXIS

Page 33: Middle East respiratory syndrome - coronavirus

INTERIM LABORATORY BIOSAFETY GUIDELINES

• TIMELY COMMUNICATION BETWEEN CLINICAL AND LABORATORY STAFF IS ESSENTIAL TO MINIMIZE THE RISK INCURRED IN HANDLING SPECIMENS FROM PATIENTS WITH POSSIBLE MERS-COV INFECTION. SUCH SPECIMENS SHOULD BE LABELED ACCORDINGLY, AND THE LABORATORY SHOULD BE ALERTED TO ENSURE PROPER SPECIMEN HANDLING.

Page 34: Middle East respiratory syndrome - coronavirus

STANDARD PRECAUTIONS• APPLY ROUTINELY IN ALL HEALTH-CARE SETTINGS FOR ALL

PATIENTS. STANDARD PRECAUTIONS INCLUDE:• HAND HYGIENE AND USE OF PERSONAL PROTECTIVE

EQUIPMENT (PPE) TO AVOID DIRECT CONTACT WITH PATIENTS’ BLOOD, BODY FLUIDS, SECRETIONS (INCLUDING RESPIRATORY SECRETIONS) AND NON-INTACT SKIN. WHEN PROVIDING CARE IN CLOSE CONTACT WITH A PATIENT WITH RESPIRATORY SYMPTOMS (E.G.-COUGHING OR SNEEZING), USE EYE PROTECTION, BECAUSE SPRAYS OF SECRETIONS MAY OCCUR. STANDARD PRECAUTIONS INCLUDE: PREVENTION OF NEEDLE-STICK OR SHARPS INJURY; SAFE WASTE MANAGEMENT;CLEANING AND DISINFECTION OF EQUIPMENT; AND CLEANING OF THE ENVIRONMENT

Page 35: Middle East respiratory syndrome - coronavirus

DROPLET PRECAUTIONS• USE A MEDICAL MASK IF WORKING WITHIN 1 METER OF THE PATIENT.

PLACE PATIENTS IN SINGLE ROOMS, OR GROUP TOGETHER THOSE WITH THE SAME ETIOLOGICAL DIAGNOSIS. IF AN ETIOLOGICAL DIAGNOSIS IS NOT POSSIBLE, GROUP PATIENTS WITH SIMILAR CLINICAL DIAGNOSIS AND BASED ON EPIDEMIOLOGICAL RISK FACTORS, WITH A SPATIAL SEPARATION OF AT LEAST 1 METER. LIMIT PATIENT MOVEMENT AND ENSURE THAT

• PATIENTS WEAR MEDICAL MASKS WHEN OUTSIDE THEIR ROOMS

Page 36: Middle East respiratory syndrome - coronavirus

AIRBORNE PRECAUTIONS• ENSURE THAT HEALTHCARE

WORKERS PERFORMING AEROSOL-GENERATING PROCEDURES USE PPE, INCLUDING GLOVES, LONG-SLEEVED GOWNS, EYE PROTECTION AND PARTICULATE RESPIRATORS (N95 OR EQUIVALENT). WHENEVER POSSIBLE, USE ADEQUATELY VENTILATED SINGLE ROOMS WHEN PERFORMING AEROSOL-GENERATING PROCEDURES

Page 37: Middle East respiratory syndrome - coronavirus

WORKING WITH POTENTIALLY INFECTIOUS MATERIALS

• LABORATORY WORKERS SHOULD WEAR PERSONAL PROTECTIVE EQUIPMENT (PPE) WHICH INCLUDES DISPOSABLE GLOVES, LABORATORY COAT/GOWN, MASK, AND EYE PROTECTION WHEN HANDLING POTENTIALLY INFECTIOUS SPECIMENS.

Page 38: Middle East respiratory syndrome - coronavirus

MERS AND TRAVEL• CDC DOES NOT RECOMMEND THAT ANYONE CHANGE THEIR TRAVEL

PLANS BECAUSE OF MERS. THE CURRENT CDC TRAVEL NOTICE IS AN ALERT (LEVEL 2), WHICH PROVIDES SPECIAL PRECAUTIONS FOR TRAVELERS. BECAUSE SPREAD OF MERS HAS OCCURRED IN HEALTHCARE SETTINGS, THE ALERT ADVISES TRAVELERS GOING TO COUNTRIES IN OR NEAR THE ARABIAN PENINSULA TO PROVIDE HEALTHCARE SERVICES TO PRACTICE CDC’S RECOMMENDATIONS FOR INFECTION CONTROL OF CONFIRMED OR SUSPECTED CASES AND TO MONITOR THEIR HEALTH CLOSELY. TRAVELLERS WHO ARE GOING TO THE AREA FOR OTHER REASONS ARE ADVISED TO FOLLOW STANDARD PRECAUTIONS, SUCH AS HAND WASHING AND AVOIDING CONTACT WITH PEOPLE WHO ARE ILL.

Page 39: Middle East respiratory syndrome - coronavirus

MANY COUNTRIES TRACKING MERS INFECTION SPREAD

Page 40: Middle East respiratory syndrome - coronavirus

•PROGRAMME CREATED AND DESIGNED BY DR.T.V.RAO MD FROM WEB RESOURCES OF WHO AND CDC FOR UNIVERSAL EDUCATION

ON INFECTIOUS DISEASES • EMAIL

[email protected]